U.S. Health Secretary Halts Enforcement on Six Unapproved Peptides

U.S. Health Secretary Halts Enforcement on Six Unapproved Peptides

Santé Politique
Connectez-vous pour épingler cet événement

U. S. Health Secretary Robert F. Kennedy Jr. announced on October 28 in Washington, D.

C. , that the Department of Health and Human Services will cease enforcement against the sale of six compounded peptide drugs, despite FDA safety warnings. The announcement follows a temporary enforcement discretion the department granted earlier in the week, stating it would not pursue legal action against compounding pharmacies that produce the six peptides while a formal rule change is pending. Most FDA scientific staff had previously voiced opposition to the proposal, citing concerns about the compounds' safety.

Acteurs

U.S. Department of Health and Human Services Emily Hilliard Dr. Peter Lurie Shabbir Safdar Medivant Healthcare

Lieux

Washington, D.C., United States

Articles

29 octobre 2026
1 au total
RFK Jr says he will allow widespread unapproved injections despite his FDA advising people not to use them
RFK Jr says he will allow widespread unapproved injections despite his FDA advising people not to use them

The Independent • 29 oct. 00h39

Robert F. Kennedy Jr. announced a policy that will stop enforcement against the sale of six compounded peptide compounds, despite FDA warnings about their safety.

Crédibilité 68% Manip. 12% Centre
28 octobre 2026
4 au total
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides

NPR • 28 oct. 22h26

The Department of Health and Human Services announced a policy allowing 503A compounding pharmacies to prepare six peptides that have not received FDA approval, sparking debate over safety and supply.

Crédibilité 73% Manip. 10% Centre
Peptide peddlers cheer as RFK Jr. unilaterally grants access, overruling FDA
Peptide peddlers cheer as RFK Jr. unilaterally grants access, overruling FDA

Ars Technica • 28 oct. 22h17

Robert F. Kennedy, the U.S. Health Secretary, announced a policy that stops HHS from enforcing against compounding pharmacies that produce six specific peptide substances, despite FDA scientists’ safety concerns.

Crédibilité 55% Manip. 45% Gauche
FDA scientists opposed Trump administration’s move to ease peptide access
FDA scientists opposed Trump administration’s move to ease peptide access

The Guardian • 28 oct. 18h35

Most FDA scientific staff opposed a Health and Human Services proposal that would limit enforcement against specialty pharmacies selling unapproved peptide drugs, citing safety concerns.

Crédibilité 68% Manip. 25% Centre
RFK Jr. takes shortcut to make some peptides more widely available
RFK Jr. takes shortcut to make some peptides more widely available

NBC News • 28 oct. 16h13

The Department of Health and Human Services will not pursue legal action against compounding pharmacies that produce six specific peptides while a formal rule change is pending.

Crédibilité 78% Manip. 30% Centre

Événements liés